Adam Silverman

Company: Spotlight Therapeutics

Job title: Vice President, Protein Sciences

Seminars:

Overcoming Gene Editor Delivery Challenges to Maximize Translational Success 2:00 pm

Explore methodologies to assess safety and efficacy in preclinical models and highlight the importance of early-stage validation to mitigate risks and optimize translational success Share progress in developing a non-viral, engineered ribonucleoprotein (eRNP) CRISPR gene editor platform enabling safe and effective gene modification via subretinal administration Examine strategies to navigate translational challenges in ophthalmic disorders…Read more

day: Day Two 12th